Centerview Partners played a pivotal role as the exclusive financial advisor in Otsuka Pharmaceutical’s strategic acquisition of Jnana Therapeutics Inc., a deal valued at up to $1.125 billion.
Otsuka, a global leader in healthcare, will enhance its portfolio in specialty and autoimmune diseases through this acquisition.
The agreement stipulates an upfront
All the week’s industry events straight to your inbox.
By signing up you agree to our terms of use and privacy policy.
7 Bell Yard, London, England, WC2A 2JR
You will soon receive a Reset Password link
By signing up you agree to terms of use and privacy policy.
Continue with Facebook Continue with Google